Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II open-label study of subcutaneous HY07121 in advanced malignant solid tumors
CTR20263272Phase 2Active
- Sponsor
- Huiyu Haiyue
- Start
- Sep 2026
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Fc Fusion Proteins → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of HY-07121 in Nonhematologic neoplasms, sponsored by Huiyu Haiyue. Started Sep 2026; status: active.
02
Drugs
HY-07121
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20263272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263272.